Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes

Clinical trial NCT02949193 · COMPLETED

Trial details

NCT number: NCT02949193
Sponsor: Dong-A ST Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2013-05-01
Primary completion: 2014-11-01
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.